These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9541607)

  • 1. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway.
    Melero I; Bach N; Hellström KE; Aruffo A; Mittler RS; Chen L
    Eur J Immunol; 1998 Mar; 28(3):1116-21. PubMed ID: 9541607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM; Lau P; Watts TH
    J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
    Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
    Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
    Kim YJ; Brutkiewicz RR; Broxmeyer HE
    Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.
    Melero I; Shuford WW; Newby SA; Aruffo A; Ledbetter JA; Hellström KE; Mittler RS; Chen L
    Nat Med; 1997 Jun; 3(6):682-5. PubMed ID: 9176498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
    Sica G; Chen L
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):275-9. PubMed ID: 10604232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
    DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
    J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.
    Chu NR; DeBenedette MA; Stiernholm BJ; Barber BH; Watts TH
    J Immunol; 1997 Apr; 158(7):3081-9. PubMed ID: 9120260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses.
    Kim YJ; Kim SH; Mantel P; Kwon BS
    Eur J Immunol; 1998 Mar; 28(3):881-90. PubMed ID: 9541583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.
    Yoshida H; Katayose Y; Unno M; Suzuki M; Kodama H; Takemura S; Asano R; Hayashi H; Yamamoto K; Matsuno S; Kudo T
    Cancer Immunol Immunother; 2003 Feb; 52(2):97-106. PubMed ID: 12594573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
    Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
    J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
    J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
    DeBenedette MA; Shahinian A; Mak TW; Watts TH
    J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.
    Kim HH; Kwack K; Lee ZH
    Mol Cells; 2000 Jun; 10(3):247-52. PubMed ID: 10901161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.